[Etretinate and 5-fluorouracil in intra-anal Bowen's disease].
A report is given on the combination of local 5-fluorouracil and systemic etretinate to treat a patient suffering from intra-anal Bowen's disease.
D000328:Adult; D001003:Anal Canal / Q000473:pathology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001005:Anus Neoplasms / Q000188:drug therapy* / Q000473:pathology; D001913:Bowen's Disease / Q000188:drug therapy* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D003131:Combined Modality Therapy; D005050:Etretinate / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D005833:Genital Neoplasms, Female / Q000188:drug therapy; D006801:Humans; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
D005050:Etretinate; D005472:Fluorouracil
Etretinat und 5-Fluorouracil bei intraanalem M. Bowen.